RRD was founded in 2002 on a basic premise: Create an alternative approach to drug development that enables more efficient use of capital and accelerates an asset's value inflection point. Our Product Development Team (PDT) partnering model anticipated the shift in early drug development from large pharma to biotech and has a long track record of value creation.
The model first defines the right strategy to optimize asset value through human proof-of-concept (hPOC) and then controls operational execution of that strategy for a more predictable achievement of value.
The model first defines the right strategy to optimize asset value through human proof-of-concept (hPOC) and then controls operational execution of that strategy for a more predictable achievement of value.
Services
The pharmaceutical industry is highly dependent on small innovator companies to fill late-stage pipeline needs. As a result, innovators are focused on achieving hPOC to monetize their development investment through a transaction with a biopharma partner or an IPO. With the end result being a high-quality hPOC data package required by regulatory agencies and potential biopharma partners.
Your RRD Product Development Team (PDT) is structurally and functionally similar to that of a core team in an established biopharmaceutical company. With an unmatched set of credentials, your team will tailor a strategy designed to optimize product value to a defined stage of development and then direct and control execution of that strategy towards optimizing outcomes.
Reviews
Be the first to review RRD International LLC.
Write a Review
